Dr Cynthia Forlini

Death determination, organ donation and the importance of the Dead Donor Rule following withdrawal of life‐sustaining treatment: a survey of community opinions

Michael O'Leary, George Skowronski, Christine Critchley, Lisa O'Reilly, Cynthia Forlini, Linda Sheahan, Cameron Stewart, Ian Kerridge

(2022), Vol. 52, pp. 238-248, Internal Medicine Journal, London, Eng., C1

Problematic risk-taking involving emerging technologies: A stakeholder framework to minimize harms

T Swanton, A Blaszczynski, C Forlini, V Starcevic, S Gainsbury

(2021), Vol. 9, pp. 869-875, Journal of Behavioral Addictions, Hungary, C1

Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce

A Atkinson, K van de Ven, M Cunningham, T de Zeeuw, E Hibbert, C Forlini, V Barkoukis, H Sumnall

(2021), Vol. 95, International Journal of Drug Policy, Netherlands, C1

The pharmaceuticalisation of 'healthy' ageing: Testosterone enhancement for longevity

M Dunn, K Mulrooney, C Forlini, K van de Ven, M Underwood

(2021), Vol. 95, International Journal of Drug Policy, Netherlands, C1

A scoping review of the perceptions of death in the context of organ donation and transplantation

G Skowronski, A Ramnani, D Walton-Sonda, C Forlini, M O’Leary, L O’Reilly, L Sheahan, C Stewart, I Kerridge

(2021), Vol. 22, BMC Medical Ethics, England, C1

Death, dying and donation: community perceptions of brain death and their relationship to decisions regarding withdrawal of vital organ support and organ donation

George Skowronski, Michael O'Leary, Christine Critchley, Lisa O'Reilly, Cynthia Forlini, Nancyz Ghinea, Linda Sheahan, Cameron Stewart, Ian Kerridge

(2020), Vol. 50, pp. 1192-1201, Internal Medicine Journal, Richmond, Vic., C1

The Hidden Curriculum in Ethics and its Relationship to Professional Identity Formation: A Qualitative Study of Two Canadian Psychiatry Residency Programs

M Gupta, C Forlini, L Laneuville

(2020), Vol. 3, pp. 80-92, Canadian Journal of Bioethics, C1

A Neuroethics Framework for the Australian Brain Initiative

J Kennett, A Carter, J Bourne, W Hall, N Levy, J Mattingley, A Lawrence, C Forlini, L Malcolm, N Vincent, L Richards, G Egan, M Breakspear, K Cornish, G Halliday, L Poole-Warren, S Sriram, T Soulis, B Fitzgibbon, I Kiral-Kornek, D Badcock, B Balleine, J Bekkers, M Berk, A Bradley, A Brichta, O Carter, A Castles, J Clements, J Cornish, G de Zubicaray, P Enticott, A Fornito, L Griffiths, J Gullifer, A Hannan, S Harrer, A Harvey, I Hickie, L Jazwinska, M Kiernan, T Kilpatrick, R Leventer, J Licinio, N Lovell, G Mackellar, S Medland, P Michie, J Nithianantharajah, J Parker, J Payne, S Rossell, P Sah, Z Sarnyai, P Schofield, D Shum, T Silk, M Slee, G Stuart, J Tapson, A van Schaik, B Vissel, A Waters, D Apthorp, S Cohen-Woods, S Conn, M Korgaonkar, A Mason, M Azghadi, O Shimoni, A Smith, M Thompson

(2019), Vol. 101, pp. 365-369, Neuron, United States, C1

An Australian community jury to consider case-finding for dementia: differences between informed community preferences and general practice guidelines

R Thomas, R Sims, E Beller, A Scott, J Doust, D Le Couteur, D Pond, C Loy, C Forlini, P Glasziou

(2019), Vol. 22, pp. 475-484, Health expectations, Chichester, Eng., C1

Non-medical prescription stimulant use to improve academic performance among Australian university students: Prevalence and correlates of use

J Lucke, C Jensen, M Dunn, G Chan, C Forlini, S Kaye, B Partridge, M Farrell, E Racine, W Hall

(2018), Vol. 18, BMC Public Health, England, C1

Public mental health ethics: helping improve mental health for individuals and communities

D Silva, C Forlini, C Meurk

(2018), Vol. 11, pp. 121-125, Public health ethics, Oxford, Eng., C1

A prospectus for ethical analysis of ageing individuals' responsibility to prevent cognitive decline

C Forlini, W Hall

(2017), Vol. 31, pp. 657-665, Bioethics, Chichester, Eng., C1

Patient preferences may be indicative of normative issues in dementia research

C Forlini

(2017), Vol. 59, pp. 11-12, Journal of alzheimer's disease, Amsterdam, Netherlands, C1

Contextualized autonomy and liberalism: Broadening the lenses on complementary and alternative medicines in preclinical Alzheimer's disease

E Racine, J Aspler, C Forlini, J Chandler

(2017), Vol. 27, pp. 1-41, Kennedy Institute of Ethics Journal, United States, C1

The hidden ethics curriculum in two Canadian psychiatry residency programs: a qualitative study

M Gupta, C Forlini, K Lenton, R Duchen, L Lohfeld

(2016), Vol. 40, pp. 592-599, Academic psychiatry, Cham, Switzerland, C1

Complementary and alternative medicine in the context of earlier diagnoses of Alzheimer's disease: opening the conversation to prepare ethical responses

E Racine, C Forlini, J Aspler, J Chandler

(2016), Vol. 51, pp. 1-9, Journal of Alzheimer's disease, Amsterdam, Netherlands, C1

The is and ought of the ethics of neuroenhancement: Mind the gap

C Forlini, W Hall

(2016), Vol. 6, Frontiers in Psychology, Switzerland, C1

Australian University Students' Coping Strategies and Use of Pharmaceutical Stimulants as Cognitive Enhancers

C Jensen, C Forlini, B Partridge, W Hall

(2016), Vol. 7, Frontiers in Psychology, Switzerland, C1

Ethical, Social and Clinical Challenges in using Deep Brain Stimulation to Treat Addiction and Other Impulsive and Compulsive Disorders

Adrian Carter, Philip Mosley, Cynthia Forlini, Wayne Hall

(2016), Vol. 19, pp. 163-188, Jahrbuch für Wissenschaft und Ethik, Berlin, Germany, C1

Ethical issues raised by a ban on the sale of electronic nicotine devices

W Hall, C Gartner, C Forlini

(2015), Vol. 110, pp. 1061-1067, Addiction, Chichester, Eng., C1

Knowledge, experiences and views of German university students toward neuroenhancement: an empirical-ethical analysis

C Forlini, J Schildmann, P Roser, R Beranek, J Vollmann

(2015), Vol. 8, pp. 83-92, Neuroethics, Dordrecht, The Netherlands, C1

Researchers' perspectives on scientific and ethical issues with transcranial direct current stimulation: an international survey

K Riggall, C Forlini, A Carter, W Hall, M Weier, B Partridge, M Meinzer

(2015), Vol. 5, pp. 1-10, Scientific reports, London, Eng., C1

Food addiction and its impact on weight-based stigma and the treatment of obese individuals in the U.S. and Australia

N Lee, W Hall, J Lucke, C Forlini, A Carter

(2014), Vol. 6, pp. 5312-5326, Nutrients, Basel, Switzerland, C1

The value and pitfalls of speculation about science and technology in bioethics: the case of cognitive enhancement

E Racine, T Martin Rubio, J Chandler, C Forlini, J Lucke

(2014), Vol. 17, pp. 325-337, Medicine, health care and philosophy, Dordrecht, The Netherlands, C1

Generating genius: how an Alzheimer's drug became considered a 'cognitive enhancer' for healthy individuals

L Wade, C Forlini, E Racine

(2014), Vol. 15, pp. 1-14, BMC medical ethics, London, Eng., C1

Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement

S Sattler, C Forlini, E Racine, C Sauer

(2013), Vol. 8, pp. 1-12, PLoS one, San Francisco, Calif., C1

Navigating the enhancement landscape: ethical issues in research on cognitive enhancers for healthy individuals

C Forlini, W Hall, B Maxwell, S Outram, P Reiner, D Repantis, M Schermer, E Racine

(2013), Vol. 14, pp. 123-128, EMBO reports, Chichester, Eng., C1

Stakeholder perspectives and reactions to "academic" cognitive enhancement: unsuspected meaning of ambivalence and analogies

C Forlini, E Racine

(2012), Vol. 21, pp. 606-625, Public understanding of science, London, Eng., C1-1

Added stakeholders, added value(s) to the cognitive enhancement debate: are academic discourse and professional policies sidestepping values of stakeholders?

C Forlini, E Racine

(2012), Vol. 3, pp. 33-47, AJOB primary research, Abingdon, Eng., C1-1

Cognitive enhancement, lifestyle choice or misuse of prescription drugs? : Ethics blind spots in current debates

E Racine, C Forlini

(2010), Vol. 3, pp. 1-4, Neuroethics, Cham, Switzerland, C1-1

Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement

C Forlini, E Racine

(2009), Vol. 10, BMC Medical Ethics, C1-1

Autonomy and coercion in academic "cognitive enhancement" using methylphenidate: Perspectives of key stakeholders

C Forlini, E Racine

(2009), Vol. 2, pp. 163-177, Neuroethics, C1-1